详情页 - 昆明医科大学第一附属医院知识库

当前位置：首页 > 详情页

Systemic inflammation-based predictors of pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.

129| 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

机构： [1]Department of Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming, China

出处：

DOI：

ISSN：

关键词： Hematological parameters locally advanced rectal cancer neoadjuvant chemoradiotherapy pathological tumor response systemic inflammation‑based predictors

摘要：

To investigate whether systemic inflammation-based predictors can predict tumor response to neoadjuvant chemoradiotherapy (CRT) in patients with locally advanced rectal cancer (LARC).Totally, 205 LARC patients undergoing neoadjuvant CRT and curative surgery between 2008 and 2017 were analyzed. After propensity score matching, 132 patients were included in the study. Hematological parameters were collected, and their relationship with tumor response was investigated.After propensity score matching, patients in good response group before CRT displayed significantly lower neutrophil-lymphocyte-ratio (NLR) and platelet-lymphocyte-ratio (PLR) than those in poor response group, while there were no significant differences in all hematological characteristics between the two groups after CRT. The cutoff values of pre-CRT NLR and pre-CRT PLR after receiver operating characteristic analysis were 3.10 and 198.7, respectively. Multivariate analysis revealed that while there was no association between pre-CRT PLR and tumor response, pre-CRT NLR ≥3.1 was identified as the predictor of poor tumor response (P = 0.007).An increased NLR before CRT can serve as a hematological factor for predicting a poor tumor response in LARC.

基金：

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2023]版：

大类 | 4 区医学

小类 | 4 区肿瘤学

最新[2023]版：

大类 | 4 区医学

小类 | 4 区肿瘤学

JCR分区：

出版当年[2022]版：

Q4 ONCOLOGY

最新[2023]版：

Q4 ONCOLOGY

影响因子： 1.4 最新[2023版] 1.3 最新五年平均 1.3 出版当年[2022版] 1.5 出版当年五年平均 1.331 出版前一年[2021版] 1.4 出版后一年[2023版]

第一作者：

第一作者机构： [1]Department of Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming, China

通讯作者：

通讯机构： [1]Department of Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming, China [*1]Department of Oncology, The First Affiliated Hospital of Kunming Medical University, No. 295 Xichang Road, Kunming 650032, China.

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Neoadjuvant Chemotherapy with CAPOX versus Chemoradiation for Locally Advanced Rectal Cancer with Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial [2]中性粒细胞与淋巴细胞比值在预测局部进展期直肠癌同期新辅助放化疗效果中的价值 [3]CONVERT: Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer Patients [4]Neoadjuvant chemotherapy with CAPOX versus chemoradiation for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): Final results of a phase III trial [5]Neoadjuvant chemotherapy with oxaliplatin and capecitabine versus chemoradiation with capecitabine for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): Initial results of a multicenter randomised, open-label, phase III trial [6]Effect of age and sex on hematological and biochemical parameters in Chinese rhesus monkeys (Macaca mulatta) anesthetized with ketamine [7]Screening of Predictive Markers of Neoadjuvant Chemoradiotherapy in Esophageal Cancer Based on Weighted Gene Co-Expression Network Analysis [8]Efficacy and safety of the "watch-and-wait" approach for rectal cancer with clinical complete response after neoadjuvant chemoradiotherapy: a meta-analysis [9]Association of Sialic Acid-Binding Immunoglobulin-Like Lectin 15 With Phenotypes in Esophageal Squamous Cell Carcinoma in the Setting of Neoadjuvant Chemoradiotherapy [10]Effectiveness comparisons of various therapies for FIGO stage IB2/IIA2 cervical cancer: a Bayesian network meta-analysis